NFKB1 and acute myeloid leukemia: To confirm this, AML cells were cultured with gilteritinib, TNFα, and gilteritinib in combination with BAY 11–7082 (an NF-κB inhibitor that inhibits TNFα-induced IκBα phosphorylation).